Orthopedic Biomaterials Market Size & Share, by Material (Ceramics & Bioactive Glasses, Polymers, Metals, Calcium Phosphate Cements); Application (Joint Reconstruction, Bio-Resorbable Tissue Fixation, Orthobiologics, Viscosupplementation, Orthopedic Implants) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3547
  • Published Date: Mar 20, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2035

Orthopedic Biomaterials Market size is estimated to cross USD 45 billion by the end of 2035, growing at a CAGR of 9% during the forecast period, i.e., 2023-2035. In the year 2022, the industry size of orthopedic biomaterials was over USD 15 billion. The major factor attributed to the growth of the market is the rising prevalence of musculoskeletal diseases all over the world. Musculoskeletal diseases in a human usually affect the joints, bones, and muscles, and aid the development of other pain conditions and inflammatory diseases. Treatment of such musculoskeletal conditions requires orthopedic biomaterials for an effective healing process which in turn is expected to propel market expansion. As per the statistics shared by the World Health Organization (WHO) in 2022, approximately 1.71 billion people were affected by musculoskeletal conditions all over the world.

In addition to the aforementioned factors, other factors that are attributed to market growth is the rising chronic skeletal conditions among the global population which requires orthopedic biomaterials in the treatment process. Furthermore, the world has seen a surge in various kinds of orthopedic illnesses owing to the high engagement in a sedentary lifestyle and consumption of fatty and processed food items. Also, the burgeoning geriatric population which is more prone to various musculoskeletal ailments is considered to positively contribute to market expansion. In addition, the escalation in the number of trauma cases owing to injuries from accidents coupled with the increased number of sports injuries is also anticipated to bring lucrative growth opportunities for market expansion during the forecast period. Moreover, the growing demand for technologically advanced orthopedic biomaterials for treating various kinds of diseases is propelling the key player in the market to invest more in research and development activities. This factor is anticipated to impetus robust revenue generation in the upcoming years. Another factor that is anticipated to aid market growth is the rising number of orthopedic surgeries such as joint arthroplasty, joint reconstruction, and viscosupplementation which is expected to generate a demand for orthopedic biomaterials.


Orthopedic Biomaterials Market
Get more information on this report: Request Free Sample PDF

Orthopedic Biomaterials Sector: Growth Drivers and Challenges

Growth Drivers

  • Growing Number of Orthopedic Surgeries Across the Globe – People nowadays are being diagnosed with numerous kinds of musculoskeletal diseases owing to unhealthy lifestyles and accidents with traumas and injuries. As a result, the demand for orthopedic biomaterials is anticipated to increase during the surgical procedures of the treatment process. Thus, a high number of orthopedic surgeries being performed is a positive indicator for market expansion during the forecast period. Recent statistics, it is revealed that approximately 5 million musculoskeletal system surgeries are performed every year in the United States region.

  • Rising Prevalence of Injuries and Accidents – People encounter different types of injuries every year. In such cases, orthopedic biomaterials are effective in treatment processes and enhance the healing process. Hence, the growing number of injuries is expected to increase the demand for orthopedic biomaterials and aid market growth in the upcoming years. The National Safety Council stated that in 2020, the United States experienced around 55.4 million injuries, out of which 200,955 were classified as preventable deaths.

  • Increasing Burden of Bone Diseases – To solve bone diseases, orthopedic biomaterials are effective in bone repair and fastening the healing processes. Therefore, the high number of cases of bone disorders is anticipated to bring in lucrative growth opportunities for market expansion. The National Library of Medicine published a report that calculated the prevalence of osteoporosis to be more than 200 million people across the world in 2019. It also has been calculated that the occurrence of osteoporosis in women around the world is more than 23% and in men around the world was found to be almost 11%.

  • Rapid Escalation in Number of Bone Fractures – For instance, in 2019, there were more than 175 million cases of fractures and approximately 450 million cases of acute or long-term symptoms of a fracture worldwide.

  • High Focus on Developing the Medical Devices Sector - The data revealed by the India Brand Equity Foundation (IBEF) stated that in FY20, the foreign investments in the Indian medical devices sector increased to USD 301 million from USD 151 million in FY19, which indicates a 98% increment.

Challenges

  • High Cost Associated with Orthopedic Biomaterials – Orthopedic biomaterials are technologically advanced medical products with the integration of the latest features. As a result, the costs of these products subsequently increase the costs of the surgical procedure and treatment. This factor is anticipated to lower the adoption rate of orthopedic biomaterials among the population with middle and low-income and ultimately hamper market growth during the forecast period.
  • Low Awareness Level About the Advantages
  • Lack of Favorable Reimbursement Policies

Orthopedic Biomaterials Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~9%

Base Year Market Size (2022)

~ USD 15 Billion

Forecast Year Market Size (2035)

~ USD 45 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Orthopedic Biomaterials Segmentation

Material (Ceramics & Bioactive Glasses, Polymers, Metals, Calcium Phosphate Cements)

The global orthopedic biomaterials market is segmented and analyzed for demand and supply by material into ceramics & bioactive glasses, polymers, metals, and calcium phosphate cements. Out of the four segments, the  polymer segment is estimated to gain the largest market share of about ~34% in the year 2035. The major factor for segment growth is the rising use of polymers as bone cement and load-bearing surfaces for total joint arthroplasties. In addition, the easy availability of cost-effective polymers and biopolymers that are advantageous for various uses in ortho biologics and bio-resorbable tissue fixation is expected to surge the demands of polymer-based orthopedic biomaterial globally and impetus segment growth. Furthermore, the advantages offered by polymers such as high flexibility, enhanced strength, and increased durability are also expected to expand their application use and help in expanding the segment size.

Application (Joint Reconstruction, Bio-Resorbable Tissue Fixation, Orthobiologics, Viscosupplementation, Orthopedic Implants)

The global orthopedic biomaterials market is also segmented and analyzed for demand and supply by application into joint reconstruction, bio-resorbable tissue fixation, ortho biologics, viscosupplementation, orthopedic implants, and others. Amongst these segments, the orthopedic implants segment is expected to garner a significant share of around ~38% in the year 2035. The major factor for segment growth is the rising number of keyhole orthopedic surgery across the world coupled with the increased prevalence of bone fractures. For instance, it has been calculated that in the United States, almost 2 million fractures occur every year. Furthermore, the rising number of bone diseases such as osteoporosis, osteopenia, osteoarthritis, osteomyelitis, and rapid escalation of musculoskeletal conditions is anticipated to fuel revenue generation and drive segment growth during the forecast period.

Our in-depth analysis of the global market includes the following segments:

          By Material

  • Ceramics & Bioactive Glasses
  • Polymers
  • Metals
  • Calcium Phosphate Cement

        By Application

  • Joint Reconstruction
  • Bio-Resorbable Tissue Fixation
  • Orthobiologics
  • Viscosupplementation
  • Orthopedic Implants
  • Others

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Orthopedic Biomaterials Industry - Regional Synopsis

APAC Market Statistics

The Asia Pacific orthopedic biomaterials market, amongst the market in all the other regions, is projected to hold the largest market share of about ~41% by the end of 2035, on the back of the growing prevalence of bone degenerative diseases in the region’s low- and middle-income economies. In addition, continuous hikes in healthcare expenditure and significant improvements in the medical infrastructure are also projected to propel APAC’s market growth in the future. Further, the presence of a strong healthcare network in the region, along with the availability of supportive policies by the regulatory bodies that promote the development of effective orthopedic biomaterials to develop efficient treatment options, are also anticipated to contribute to the market growth in the region. In addition, the rising commercialization of medical products along with the burgeoning population is also anticipated to boost market growth during the forecast period.

North American Market Forecast

The North American orthopedic biomaterials market, amongst the market in all the other regions, is projected to hold the second largest share of about ~31% during the forecast period. Factors that are anticipated to create a positive outlook for market growth during the forecast period are the presence of a large pool of patients diagnosed with various kinds of musculoskeletal diseases and bone disorders who need orthopedic biomaterials for faster treatment procedures. In addition, the rising investments in the research and development activities by the major key player operating in the market for developing advanced and better orthopedic biomaterials are also anticipated to fuel market growth in the region. Furthermore, Rising disposable income has resulted in increased spending capacity, which is predicted to motivate Americans to adopt advanced medical devices such as orthopedic biomaterials and is It is expected to bring revenue raising opportunities.

Europe Market Forecast

Further, the market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The rising focus on health and fitness along with the availability of a high number of medical care settings to receive treatment is considered to be a factor driving market growth during the forecast period. Other factors include the presence of a high number of hospitals and a high number of inpatients and outpatients visiting the hospitals along with the availability of favorable reimbursement policies. The increased number of bone fractures along with injuries, accidents, and traumas among the European people is also estimated to generate the demand for orthopedic biomaterials and expand the market size during the forecast period.

Research Nester
Orthopedic Biomaterials Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Orthopedic Biomaterials Landscape

top-features-companies
    • Evonik Industries AG
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Stryker Corporation
    • DePuy Synthes Inc.
    • Zimmer Biomet Holdings Inc.
    • Invibio Ltd.
    • Koninklijke DSM N.V.
    • Victrex Plc.
    • Heraeus Holding GmbH
    • Exactech Inc.
    • Collagen Matrix Inc.

In the News

  • Evonik Industries AG has launched the latest osteoconductive Polyether Ether Ketone (PEEK), which is an effective biomaterial that is expected to improve the fusion between bone and an implant.

  • Stryker Corporation has developed the newest Citrelock Tendon Fixation Device System that provides surgeons a differentiated design owing to the tendon thread with a resorbable technology. It also has unique chemical and mechanical properties for orthopedic surgical applications.

Author Credits:  Radhika Pawar


  • Report ID: 3547
  • Published Date: Mar 20, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving the market growth are rising incidences of musculoskeletal disorders and other chronic skeletal conditions and the increasing geriatric population globally.

The market is anticipated to attain a CAGR of 9% over the forecast period, i.e., 2023-2035.

Lack of reimbursement related to orthopedics along with high costs of orthopedic biomaterials and low level of awareness about the advantages of orthopedic biomaterials are estimated to be the growth hindering factors for the market expansion.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Evonik Industries AG, Stryker Corporation, DePuy Synthes Inc., Zimmer Biomet Holdings Inc., Invibio Ltd., Koninklijke DSM N.V., Victrex Plc., Heraeus Holding GmbH, Exactech Inc., Collagen Matrix Inc., and other key players.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by material, application, and by region.

The orthopedic implants segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Orthopedic Biomaterials Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying